Lack of uniformity in evaluation of endoscopic prognostic features of bleeding ulcers☆,☆☆,★,★★
Section snippets
METHODS
Fourteen slides of endoscopic photographs of ulcers with typical SRH or a clean base were chosen by the three authors, all of whom have extensive experience in examining patients with upper gastrointestinal bleeding and all of whom have performed randomized controlled trials in patients with bleeding ulcers to assess the relationship of outcome to SRH.5, 7, 8, 9, 10, 11 More than 250 slides were examined to pick the final 14 photographs, and all three authors independently identified each of
RESULTS
Demographic information is shown in Table 1. One hundred eighty-four (91%) participants were gastroenterologists, 5 (2%) were surgeons, 7 (3%) were internists, and 6 (3%) had other specialties. Twenty-three percent of all respondents (21% of gastroenterology respondents) were fellows, 24% had been out of training 0 to 5 years, and the remainder were more than 5 years removed from their endoscopic training. Ninety-five percent of all respondents (98% of gastroenterologists) performed more than 5
DISCUSSION
The appearance of an ulcer base at endoscopy provides important prognostic information in patients presenting with upper gastrointestinal bleeding. However, definitions of SRH, if they are provided at all, vary from study to study, and no uniform criteria are available. This lack of consensus may make the labeling of SRH as clots or visible vessels especially difficult. For example, the prevalence of clots in patients presenting with bleeding ulcers ranges from 012 to 49%13; in the former study
Acknowledgements
The authors would like to thank the officers of the American College of Gastroenterology and the directors of the 1992 Postgraduate Course for their assistance in allowing us to perform this study; IRIS, Inc., which ran the interactive session and provided us with the rough data for each of the questions; Dr. Oliver Cass for his assistance with the collection and preparation of the digital endoscopic slides; and, most importantly, the 202 participants who cooperated in answering the questions
References (22)
- et al.
The national ASGE survey on upper gastrointestinal bleeding. I. Study design and baseline data
Gastrointest Endosc
(1981) - et al.
Pro spective evaluation of immediate versus delayed refeeding and prognostic value of endoscopic findings in patients with upper gastrointestinal hemorrhage
Gastroenterology
(1992) Multipolar electrocoagulation vs. injection therapy in the treatment of bleeding peptic ulcers: a prospective, randomized trial
Gastroenterology
(1990)- et al.
The non-bleeding visible vessel versus the sentinel clot: natural history and risk of rebleeding
Gastrointest Endosc
(1993) Endoscopic electrocoagulation in the management of upper gastrointestinal tract bleeding
Surg Clin North Am
(1982)- et al.
Gastroesophageal endoscopic features in cirrhosis: observer variability, interassociations, and relationship to hepatic dysfunction
Gastroenterology
(1990) Epidemiology for upper gastrointestinal bleeding
Gastrointest Endosc
(1990)Upper gastrointestinal hemorrhage
West J Med
(1991)Therapeutic endoscopy and bleeding ulcers
JAMA
(1989)- et al.
Can ulcer bleeding patients without stigmata of recent haemorrhage be discharged on the same day—a retrospective and prospective study
Gastroenterology
(1992)
Multipolar electrocoagulation in the treatment of active upper gastrointestinal hemorrhage: a prospective, controlled trial
N Engl J Med
Cited by (77)
Use of Doppler Probe in Nonvariceal Upper-Gastrointestinal Bleeding Is Less Costly and More Effective Than Standard of Care
2019, Clinical Gastroenterology and HepatologyDoppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding
2016, Gastrointestinal EndoscopyEndoscopic management of acute peptic ulcer bleeding
2014, Gastroenterology Clinics of North AmericaCitation Excerpt :Older data predating the routine use of endoscopic hemostasis reveal a natural history with rebleeding rates of 55% (17%–100%) (Forrest IA and IB), 43% (0%–81%) (Forrest IIA), 22% (14%–36%) (Forrest IIB), 10% (0%–13%) (Forrest IIC), and 5% (0%–10%) (Forrest III).34 Significant interobserver variability has been reported in the identification of endoscopic stigmata.35 Nonetheless, when ulcer bleeding stigmata are surveyed with sequential endoscopic evaluations, an evolution of stigmata is noted, suggesting various phases of healing whereby a bleeding vessel progressively evolves after endoscopic therapy into a clean base ulcer.32
Epidemiology and diagnosis of acute nonvariceal upper gastrointestinal bleeding
2014, Gastroenterology Clinics of North AmericaCitation Excerpt :Not all exposed vessels carry the same risk of recurrent bleeding, however, with pale, protuberant vessels shown much more risky than dark, flattened ones.74 The distinction between NBVV and clots can be difficult75,76; hence the presence of an NBVV may not be in itself a sufficiently reliable indicator to select patients for invasive therapy. Enhanced endoscopic imaging of bleeding ulcers to identify and characterize an involved buried vessel may allow for more cost-effective management.
Acute non-variceal upper gastrointestinal bleeding
2013, Core Topics in General and Emergency Surgery, Fifth EditionNew Diagnostic Imaging Technologies in Nonvariceal Upper Gastrointestinal Bleeding
2011, Gastrointestinal Endoscopy Clinics of North America
- ☆
From the U.S.C. School of Medicine, Los Angeles, California, and Hennepin County Medical Center, Minneapolis, Minnesota.
- ☆☆
Reprint requests: Loren Laine, MD, GI Division (LAC 12-137), Department of Medicine, U.S.C. School of Medicine, 2025 Zonal Ave., Los Angeles, CA 90033.
- ★
GASTROINTESTINAL ENDOSCOPY
- ★★
37/1/54113